Table 3.

The Associations of Baseline Characteristics on ARI, Days off because of ARI, and Cathelicidine Through 14-wk Follow-up

ARI (N = 403)D Off Because of ARI (N = 399)Cathelicidin (N = 401)
≥2 versus 0–1≥6 versus 0–5≥55 versus < 55
OR (95% CI)OR (95% CI)OR (95% CI)
S-25(OH)D (nmol/L)
 ≥501.001.001.00
 <502.11 (1.19–3.74)2.26 (1.27–4.03).49 (.24–.99)
Season
 Summer1.001.001.00
 Winter1.95 (1.10–3.45)1.25 (.70–2.25)1.06 (.57–1.95)
Use of vitamin D supplement
 Yes1.001.001.00
 No1.44 (.76–2.70).94 (.49–1.79).74 (.37–1.46)
Body mass index
 <251.001.001.00
 ≥25.86 (.50–1.48).75 (.43–1.30)1.33 (.77–2.30)
Aerobic fitness (m)
 ≥25001.001.001.00
 <25001.60 (.93–2.75)1.66 (.96–2.85)1.30 (.75–2.27)
Interactions
 S-25(OH)D*GroupP = .75P = .24P = .45
 S-25(OH)D*SeasonP = .29P = .17P = .78
ARI (N = 403)D Off Because of ARI (N = 399)Cathelicidin (N = 401)
≥2 versus 0–1≥6 versus 0–5≥55 versus < 55
OR (95% CI)OR (95% CI)OR (95% CI)
S-25(OH)D (nmol/L)
 ≥501.001.001.00
 <502.11 (1.19–3.74)2.26 (1.27–4.03).49 (.24–.99)
Season
 Summer1.001.001.00
 Winter1.95 (1.10–3.45)1.25 (.70–2.25)1.06 (.57–1.95)
Use of vitamin D supplement
 Yes1.001.001.00
 No1.44 (.76–2.70).94 (.49–1.79).74 (.37–1.46)
Body mass index
 <251.001.001.00
 ≥25.86 (.50–1.48).75 (.43–1.30)1.33 (.77–2.30)
Aerobic fitness (m)
 ≥25001.001.001.00
 <25001.60 (.93–2.75)1.66 (.96–2.85)1.30 (.75–2.27)
Interactions
 S-25(OH)D*GroupP = .75P = .24P = .45
 S-25(OH)D*SeasonP = .29P = .17P = .78

Multivariable-adjusted logistic regression. Interaction effects between S-25(OH)D with group and season were tested. Statistically nonsignificant interactions P ≥ .05 were excluded from the models.

Abbreviations: S-25(OH)D, Serum 25(OH)D; ARI, acute respiratory infection; CI, confidence interval; OR, odds ratio.

Table 3.

The Associations of Baseline Characteristics on ARI, Days off because of ARI, and Cathelicidine Through 14-wk Follow-up

ARI (N = 403)D Off Because of ARI (N = 399)Cathelicidin (N = 401)
≥2 versus 0–1≥6 versus 0–5≥55 versus < 55
OR (95% CI)OR (95% CI)OR (95% CI)
S-25(OH)D (nmol/L)
 ≥501.001.001.00
 <502.11 (1.19–3.74)2.26 (1.27–4.03).49 (.24–.99)
Season
 Summer1.001.001.00
 Winter1.95 (1.10–3.45)1.25 (.70–2.25)1.06 (.57–1.95)
Use of vitamin D supplement
 Yes1.001.001.00
 No1.44 (.76–2.70).94 (.49–1.79).74 (.37–1.46)
Body mass index
 <251.001.001.00
 ≥25.86 (.50–1.48).75 (.43–1.30)1.33 (.77–2.30)
Aerobic fitness (m)
 ≥25001.001.001.00
 <25001.60 (.93–2.75)1.66 (.96–2.85)1.30 (.75–2.27)
Interactions
 S-25(OH)D*GroupP = .75P = .24P = .45
 S-25(OH)D*SeasonP = .29P = .17P = .78
ARI (N = 403)D Off Because of ARI (N = 399)Cathelicidin (N = 401)
≥2 versus 0–1≥6 versus 0–5≥55 versus < 55
OR (95% CI)OR (95% CI)OR (95% CI)
S-25(OH)D (nmol/L)
 ≥501.001.001.00
 <502.11 (1.19–3.74)2.26 (1.27–4.03).49 (.24–.99)
Season
 Summer1.001.001.00
 Winter1.95 (1.10–3.45)1.25 (.70–2.25)1.06 (.57–1.95)
Use of vitamin D supplement
 Yes1.001.001.00
 No1.44 (.76–2.70).94 (.49–1.79).74 (.37–1.46)
Body mass index
 <251.001.001.00
 ≥25.86 (.50–1.48).75 (.43–1.30)1.33 (.77–2.30)
Aerobic fitness (m)
 ≥25001.001.001.00
 <25001.60 (.93–2.75)1.66 (.96–2.85)1.30 (.75–2.27)
Interactions
 S-25(OH)D*GroupP = .75P = .24P = .45
 S-25(OH)D*SeasonP = .29P = .17P = .78

Multivariable-adjusted logistic regression. Interaction effects between S-25(OH)D with group and season were tested. Statistically nonsignificant interactions P ≥ .05 were excluded from the models.

Abbreviations: S-25(OH)D, Serum 25(OH)D; ARI, acute respiratory infection; CI, confidence interval; OR, odds ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close